Lauren Hollins, MD
Dermatology · Hershey, PANPI 1437532561
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $63,373 of the $84,438 with a category attached, or 75.1%. Regeneron Healthcare Solutions, Inc. accounts for 66.2% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $66,161, more than ten times the $107 reported in 2019. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $870.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$56K
- Sanofi$15K
- Lilly USA, LLC$10K
- Arcutis Biotherapeutics, Inc.$2K
- Johnson & Johnson$518
- Novartis$177
- plus $268 from 3 others
What the payments were for
- Consulting fees$9,13811%
- Speaking & faculty fees$63,37375%
- Travel & lodging$8,0199%
- Food & beverage$3,8055%
- Education$1040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 61 | $55,910 |
| Sanofi | 9 | $14,926 |
| Lilly USA, LLC | 14 | $10,242 |
| Arcutis Biotherapeutics, Inc. | 4 | $2,398 |
| Johnson & Johnson | 4 | $518 |
| Novartis | 2 | $177 |
| Amgen | 1 | $124 |
| Kyowa Kirin, Inc. | 1 | $106 |
| Sun Pharmaceutical Industries Inc. | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$84,438 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 12 | $232,699 |
| Humira(Cf) PenAdalimumab | 14 | $90,712 |
| Humira PenAdalimumab | 13 | $87,254 |
| Dupixent PenDupilumab | 22 | $78,622 |
| Dupixent SyringeDupilumab | 20 | $68,644 |
| Tretinoin | 49 | $2,788 |
| Clobetasol Propionate | 71 | $1,874 |
| Doxycycline Hyclate | 29 | $1,131 |
| Metronidazole | 14 | $1,046 |
| Minoxidil | 62 | $856 |
| Triamcinolone Acetonide | 59 | $578 |
| Ketoconazole | 28 | $396 |
| Fluocinonide | 12 | $389 |
| ValacyclovirValacyclovir Hcl | 14 | $247 |
| Finasteride | 15 | $160 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hershey
- Joslyn Sciacca-KirbyHershey$405K
- Andrea ZaengleinHershey$63K
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.